Tag Archives: Drug

FDA approves first biosimilar to Roche cancer drug Rituxan

(Reuters) – Celltrion Inc’s Truxima on Wednesday became the first biosimilar to Roche Holding AG’s $ 7-billion-per-year cancer drug Rituxan to be approved in the United States to treat non-Hodgkin’s lymphoma. FILE PHOTO: The logo of Celltrion is seen at company’s headquarters in Incheon, South Korea, October 28, 2016. REUTERS/Kim Hong-Ji The approval by the… Read More »

CMS proposes giving Part D plans greater negotiating power with drug manufacturers.

The Centers for Medicare and Medicaid Services is considering implementing a policy to ensure enrollees pay the lowest possible price for a prescription drug at the pharmacy counter, after taking into account back-end payments from pharmacies to plans. The policy is being proposed for an as yet-set plan year, but as early as 2020. It… Read More »